These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9504864)

  • 41. Connexin mutations in X-linked Charcot-Marie-Tooth disease.
    Bergoffen J; Scherer SS; Wang S; Scott MO; Bone LJ; Paul DL; Chen K; Lensch MW; Chance PF; Fischbeck KH
    Science; 1993 Dec; 262(5142):2039-42. PubMed ID: 8266101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Connexins in disease.
    Bennett MV
    Nature; 1994 Mar; 368(6466):18-9. PubMed ID: 8107878
    [No Abstract]   [Full Text] [Related]  

  • 43. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
    Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
    Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gap junctions and connexin-interacting proteins.
    Giepmans BN
    Cardiovasc Res; 2004 May; 62(2):233-45. PubMed ID: 15094344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation and function of liver gap junctions and their genes.
    Spray DC; Bai S; Burk RD; Saez JC
    Prog Liver Dis; 1994; 12():1-18. PubMed ID: 7746869
    [No Abstract]   [Full Text] [Related]  

  • 46. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression.
    Aasen T; Hodgins MB; Edward M; Graham SV
    Oncogene; 2003 Sep; 22(39):7969-80. PubMed ID: 12970745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes.
    Rabadan-Diehl C; Dahl G; Werner R
    FEBS Lett; 1994 Aug; 351(1):90-4. PubMed ID: 8076700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in connexin genes and disease.
    Pfenniger A; Wohlwend A; Kwak BR
    Eur J Clin Invest; 2011 Jan; 41(1):103-16. PubMed ID: 20840374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gap junctions--major structures promoting intercellular communication].
    Shubich MG; Ermoshenko BG; Perov IuM; Dorofeeva IV
    Morfologiia; 2005; 127(1):65-71. PubMed ID: 16080356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
    Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
    Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gap junctions in inherited human disorders of the central nervous system.
    Abrams CK; Scherer SS
    Biochim Biophys Acta; 2012 Aug; 1818(8):2030-47. PubMed ID: 21871435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and functions of neuronal gap junctions.
    Söhl G; Maxeiner S; Willecke K
    Nat Rev Neurosci; 2005 Mar; 6(3):191-200. PubMed ID: 15738956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gap junctions and cancer: new functions for an old story.
    Cronier L; Crespin S; Strale PO; Defamie N; Mesnil M
    Antioxid Redox Signal; 2009 Feb; 11(2):323-38. PubMed ID: 18834328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease.
    Da Y; Wang W; Liu Z; Chen H; Di L; Previch L; Chen Z
    Neurol Res; 2016 Oct; 38(10):897-902. PubMed ID: 27367520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gap junctions in the control of vascular function.
    Figueroa XF; Duling BR
    Antioxid Redox Signal; 2009 Feb; 11(2):251-66. PubMed ID: 18831678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln).
    Senderek J; Bergmann C; Quasthoff S; Ramaekers VT; Schröder JM
    Acta Neuropathol; 1998 May; 95(5):443-9. PubMed ID: 9600589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes.
    Kleopa KA; Orthmann JL; Enriquez A; Paul DL; Scherer SS
    Glia; 2004 Sep; 47(4):346-57. PubMed ID: 15293232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease.
    Saffitz JE; Hames KY; Kanno S
    J Membr Biol; 2007 Aug; 218(1-3):65-71. PubMed ID: 17585361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional redundancy and compensation among members of gap junction protein families?
    Bedner P; Steinhäuser C; Theis M
    Biochim Biophys Acta; 2012 Aug; 1818(8):1971-84. PubMed ID: 22044799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gap junctions and connexin hemichannels in the regulation of haemostasis and thrombosis.
    Vaiyapuri S; Flora GD; Gibbins JM
    Biochem Soc Trans; 2015 Jun; 43(3):489-94. PubMed ID: 26009196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.